A patient with the novel coronavirus disease COVID-19 saw symptoms improve after being treated with Sanofi’s immune modulator Plaquenil (hydroxychloroquine sulfate), according to the latest report posted on the website of the Japanese Association for Infectious Diseases.

The report posted on March 10 details the clinical course followed by a 69-year old man who was given Plaquenil, among other drugs, without disclosing the name of the institutions that treated him. The patient, who is on dialysis, was also given several antibiotics and the anti-flu agent Rapiacta (peramivir) before receiving Plaquenil. The report pointed out that while it is possible that the antibiotics and Rapiacta helped improve his symptoms, and also that the body fluid management through dialysis might have paid off, it is most likely that the use of Plaquenil led to the improvement.

In the past, Plaquenil was used as a treatment for SARS (severe acute respiratory syndrome), and for COVID-19, its use and clinical efficacy has been reported in China.

Read the original article here: https://pj.jiho.jp/article/

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »